Lataa...
Leukocytoclastic vasculitis drug reaction to certolizumab pegol
Tumor necrosis factor (TNF)-alpha antagonists are a common treatment modality for autoimmune disorders, but their use can be associated with many side effects, including various dermatologic conditions. Certolizumab pegol, a newer TNF antagonist that lacks the Fc portion of the IgG antibody, has rec...
Tallennettuna:
| Julkaisussa: | Proc (Bayl Univ Med Cent) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baylor Health Care System
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349833/ https://ncbi.nlm.nih.gov/pubmed/28405087 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|